Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

TELA Bio, Inc. (TELA) Stock Forecast 2025 - AI Price Prediction & Analysis

TELA Bio, Inc. (TELA) AI Stock Price Forecast & Investment Analysis

TELA Bio, Inc. Stock Price Chart and Technical Analysis

Loading TELA Bio, Inc. interactive price chart and technical analysis...

TELA Bio, Inc. (TELA) - Comprehensive Stock Analysis & Investment Research

Deep dive into TELA Bio, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about TELA Bio, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For TELA Bio, Inc.: TELA Bio, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

TELA Bio, Inc. (Stock Symbol: TELA) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 205 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing TELA Bio, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TELA Bio, Inc.: With $75M in annual revenue and -32.2% net margin, the company demonstrates developing profitability.

Annual Revenue: $75 million generating a -32.2% net profit margin .

Market Capitalization: $46 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -139.2% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for TELA Bio, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For TELA Bio, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for TELA Bio, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: TELA Bio, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For TELA Bio, Inc.: Market positioning analysis based on available financial and operational metrics.

TELA Bio, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 34.0% gross margin, indicating strong pricing power and operational efficiency.

TELA Bio, Inc. (TELA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for TELA Bio, Inc. stock analysis.

Loading TELA Bio, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into TELA Bio, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if TELA Bio, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For TELA Bio, Inc.: With a P/E ratio of -1.80, the market sees the stock as potentially undervalued.

P/E Ratio -1.80x
P/B Ratio 29.54x
Market Cap $46M
EPS $-1.06
Book Value/Share $0.04
Revenue/Share $1.90
FCF/Share $-1.71
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently TELA Bio, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TELA Bio, Inc.: An ROE of -139.2% indicates room for improvement in shareholder value creation.

ROE -139.2%
ROA -53.9%
ROIC -56.3%
Gross Margin 34.0%
Operating Margin -29.8%
Net Margin -32.2%
EBT Margin -113.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess TELA Bio, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For TELA Bio, Inc.: A current ratio of 4.10 indicates strong liquidity.

Current Ratio 4.10x
Quick Ratio 3.04x
D/E Ratio 3.15x
Financial Leverage 5.51x
Interest Coverage -9.0x
Working Capital $77M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal TELA Bio, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For TELA Bio, Inc.: Free cash flow of $-33M indicates cash challenges that need attention.

Operating Cash Flow $-32M
Free Cash Flow $-33M
Capital Spending $-1M
FCF/Sales -104.4%
CapEx/Sales 3.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively TELA Bio, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For TELA Bio, Inc.: An asset turnover of 0.47x suggests room for improvement in asset utilization.

Asset Turnover 0.47x
Receivables Turnover 9.0x
Inventory Turnover 1.5x
Fixed Assets Turnover 18.8x
Days Sales Outstanding 41 days
Days Inventory 238 days
Payables Period 106 days
Cash Conversion Cycle 173 days
Understanding Financial Statement Data

What these metrics mean: Key figures from TELA Bio, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For TELA Bio, Inc.: With annual revenue of $75M, TELA Bio, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $75M
R&D Expense $9M
SG&A Expense $142M
Cost of Goods Sold $20M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 91%
Cash & Short-term Investments 60%
Total Liabilities 82%
Short-term Debt 6%
Accounts Receivable 8%
Inventory 19%
Dividend & Shareholder Information
Shares Outstanding 40M
Growth Metrics (YoY)
EPS Growth -63.6%

Latest TELA Bio, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting TELA Bio, Inc. (TELA) stock price and investment outlook.

📰 We are currently updating our news feed for TELA Bio, Inc.. Check back soon for the latest market analysis and company updates.

TELA Bio, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of TELA Bio, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $12M x 1.6x
AEMD Unlock Forecast - 30 Days FREE Trial $3M -0.1x 0.5x
ALUR Unlock Forecast - 30 Days FREE Trial $10M -0.4x -0.3x
AMIX Unlock Forecast - 30 Days FREE Trial $6M x 1.0x
ANGO Unlock Forecast - 30 Days FREE Trial $510M -1.4x 2.9x
ANIK Unlock Forecast - 30 Days FREE Trial $142M -4.3x 1.0x
AORT Unlock Forecast - 30 Days FREE Trial $2140M -198.2x 4.9x
APYX Unlock Forecast - 30 Days FREE Trial $151M -3.5x 25.8x
ARAY Unlock Forecast - 30 Days FREE Trial $119M -9.9x 1.9x
ATEC Unlock Forecast - 30 Days FREE Trial $3374M -7.4x 293.2x
ATRC Unlock Forecast - 30 Days FREE Trial $1791M -39.6x 3.8x
AVHHL Unlock Forecast - 30 Days FREE Trial $22M x x
BAX Unlock Forecast - 30 Days FREE Trial $9720M -94.9x 1.3x
BBNX Unlock Forecast - 30 Days FREE Trial $1358M x 4.6x
BDX Unlock Forecast - 30 Days FREE Trial $55942M 34.1x 2.2x
BEAT Unlock Forecast - 30 Days FREE Trial $27M -5.7x 66.1x
BJDX Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.6x
BSX Unlock Forecast - 30 Days FREE Trial $150834M 61.0x 6.5x
BTCY Unlock Forecast - 30 Days FREE Trial $12M -2.7x -0.1x
BVS Unlock Forecast - 30 Days FREE Trial $526M -18.3x 3.2x
CARL Unlock Forecast - 30 Days FREE Trial $431M x 4.0x
CERS Unlock Forecast - 30 Days FREE Trial $335M -13.8x 5.4x
CLPT Unlock Forecast - 30 Days FREE Trial $411M -23.5x 25.9x
CODX Unlock Forecast - 30 Days FREE Trial $16M -0.7x 0.4x
CTSO Unlock Forecast - 30 Days FREE Trial $44M -1.8x 4.9x
CVRX Unlock Forecast - 30 Days FREE Trial $258M -5.5x 5.4x
DCTH Unlock Forecast - 30 Days FREE Trial $326M 160.2x 2.8x
DHAI Unlock Forecast - 30 Days FREE Trial $1M x -0.3x
DRIO Unlock Forecast - 30 Days FREE Trial $94M 0.6x 1.3x
DRTS Unlock Forecast - 30 Days FREE Trial $318M x 3.7x
DXCM Unlock Forecast - 30 Days FREE Trial $24387M 49.1x 9.0x
DYNT Unlock Forecast - 30 Days FREE Trial $1M -0.2x 0.3x
EBRCZ Unlock Forecast - 30 Days FREE Trial $270M x 7.0x
ECIA Unlock Forecast - 30 Days FREE Trial $3M x 1.8x
EMBC Unlock Forecast - 30 Days FREE Trial $735M 15.8x -0.8x
EMED Unlock Forecast - 30 Days FREE Trial $0M x x
FEMY Unlock Forecast - 30 Days FREE Trial $44M -1.4x 9.6x
FOFA Unlock Forecast - 30 Days FREE Trial $16M x 20.0x
GCTK Unlock Forecast - 30 Days FREE Trial $5M 0.9x 1.7x
GIPL Unlock Forecast - 30 Days FREE Trial $5M x 25.8x
GKOS Unlock Forecast - 30 Days FREE Trial $6048M -46.3x 7.9x
GMED Unlock Forecast - 30 Days FREE Trial $12498M 24.1x 2.8x
GUTS Unlock Forecast - 30 Days FREE Trial $185M x 13.8x
HAE Unlock Forecast - 30 Days FREE Trial $3775M 26.1x 4.5x
HRGN Unlock Forecast - 30 Days FREE Trial $32M x 20.4x
IART Unlock Forecast - 30 Days FREE Trial $1005M 200.2x 1.0x
ICCM Unlock Forecast - 30 Days FREE Trial $41M x 14.3x
ICU Unlock Forecast - 30 Days FREE Trial $10M -1.1x 0.9x
ICUI Unlock Forecast - 30 Days FREE Trial $3682M -49.8x 1.7x
IDXG Unlock Forecast - 30 Days FREE Trial $4M 0.8x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $22M x 5.1x
IINNW Unlock Forecast - 30 Days FREE Trial $8M x 1.7x
INBS Unlock Forecast - 30 Days FREE Trial $6M -0.3x 1.7x
INFU Unlock Forecast - 30 Days FREE Trial $192M 40.8x 3.5x
INSP Unlock Forecast - 30 Days FREE Trial $3699M 43.2x 5.6x
IRMD Unlock Forecast - 30 Days FREE Trial $1181M 48.3x 12.0x
IRTC Unlock Forecast - 30 Days FREE Trial $6011M -20.2x 49.3x
KIDS Unlock Forecast - 30 Days FREE Trial $435M -20.7x 1.3x
KMTS Unlock Forecast - 30 Days FREE Trial $1386M x x
KRMD Unlock Forecast - 30 Days FREE Trial $221M -19.8x 13.4x
LMAT Unlock Forecast - 30 Days FREE Trial $1910M 43.4x 5.0x
LNSR Unlock Forecast - 30 Days FREE Trial $115M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $138M -0.6x 5.4x
LUNG Unlock Forecast - 30 Days FREE Trial $59M -4.3x 1.0x
LYRA Unlock Forecast - 30 Days FREE Trial $5M -0.1x 4.6x
MBOT Unlock Forecast - 30 Days FREE Trial $120M -1.3x 1.5x
MCAG Unlock Forecast - 30 Days FREE Trial $33M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $31M x -9.9x
MDAI Unlock Forecast - 30 Days FREE Trial $39M -1.3x -42.3x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.2x 12.2x
MDXG Unlock Forecast - 30 Days FREE Trial $1019M 30.5x 4.3x
MGRM Unlock Forecast - 30 Days FREE Trial $217M -10.7x 25.1x
MHUA Unlock Forecast - 30 Days FREE Trial $381M x 2.3x
MMM Unlock Forecast - 30 Days FREE Trial $90733M 26.8x 19.6x
MMSI Unlock Forecast - 30 Days FREE Trial $5183M 41.1x 3.4x
MODD Unlock Forecast - 30 Days FREE Trial $25M -2.1x 2.9x
NEPH Unlock Forecast - 30 Days FREE Trial $52M 39.1x 6.2x
NMTC Unlock Forecast - 30 Days FREE Trial $32M -1.7x 3.9x
NPCE Unlock Forecast - 30 Days FREE Trial $549M -10.4x 29.7x
NSPR Unlock Forecast - 30 Days FREE Trial $82M -4.3x 1.3x
NUMD Unlock Forecast - 30 Days FREE Trial $2M x x
NVCR Unlock Forecast - 30 Days FREE Trial $1429M -20.8x 4.2x
NXGL Unlock Forecast - 30 Days FREE Trial $13M -6.8x 2.6x
OBIO Unlock Forecast - 30 Days FREE Trial $256M -3.4x 2.6x
ODYY Unlock Forecast - 30 Days FREE Trial $5M x x
OFIX Unlock Forecast - 30 Days FREE Trial $638M -5.8x 1.4x
OSRH Unlock Forecast - 30 Days FREE Trial $15M x 0.2x
OSUR Unlock Forecast - 30 Days FREE Trial $164M 17.1x 0.5x
PAVM Unlock Forecast - 30 Days FREE Trial $8M 0.1x 0.2x
PDEX Unlock Forecast - 30 Days FREE Trial $107M 10.3x 2.6x
PEN Unlock Forecast - 30 Days FREE Trial $11617M 67.4x 8.6x
PETV Unlock Forecast - 30 Days FREE Trial $35M -1.4x 8.3x
PLRZ Unlock Forecast - 30 Days FREE Trial $4M x 0.2x
PLSE Unlock Forecast - 30 Days FREE Trial $934M -2.6x 10.1x
PMI Unlock Forecast - 30 Days FREE Trial $167M x 21.0x
PODD Unlock Forecast - 30 Days FREE Trial $23625M 97.8x 17.1x
PRCT Unlock Forecast - 30 Days FREE Trial $1770M -45.4x 4.7x
PROF Unlock Forecast - 30 Days FREE Trial $181M x 5.6x
PSTV Unlock Forecast - 30 Days FREE Trial $70M -0.3x 13.8x
PYPD Unlock Forecast - 30 Days FREE Trial $56M x 2.8x
RCEL Unlock Forecast - 30 Days FREE Trial $116M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $33M x 15.0x
RMD Unlock Forecast - 30 Days FREE Trial $37221M 27.7x 6.1x
RSMDF Unlock Forecast - 30 Days FREE Trial $3551M 2.6x 0.6x
RTGN Unlock Forecast - 30 Days FREE Trial $60M x x
RVP Unlock Forecast - 30 Days FREE Trial $24M -0.9x 0.3x
SGHT Unlock Forecast - 30 Days FREE Trial $440M -3.7x 6.9x
SIBN Unlock Forecast - 30 Days FREE Trial $843M -14.3x 4.9x
SIGY Unlock Forecast - 30 Days FREE Trial $2M x x
SKIN Unlock Forecast - 30 Days FREE Trial $168M -1.8x 2.6x
SNOA Unlock Forecast - 30 Days FREE Trial $5M -5.6x 1.4x
SNWV Unlock Forecast - 30 Days FREE Trial $295M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $14789M 32.9x 3.0x
SRTS Unlock Forecast - 30 Days FREE Trial $66M 31.6x 1.3x
SSKN Unlock Forecast - 30 Days FREE Trial $7M -8.0x 5.0x
STIM Unlock Forecast - 30 Days FREE Trial $90M -1.0x 3.3x
STME Unlock Forecast - 30 Days FREE Trial $15M x x
STSS Unlock Forecast - 30 Days FREE Trial $78M -2.5x 0.2x
SYK Unlock Forecast - 30 Days FREE Trial $143890M 50.7x 12.3x
TCMD Unlock Forecast - 30 Days FREE Trial $579M 22.3x 2.8x
TELA Unlock Forecast - 30 Days FREE Trial $46M -1.8x 29.5x
TFX Unlock Forecast - 30 Days FREE Trial $5160M 31.0x 1.4x
TLSI Unlock Forecast - 30 Days FREE Trial $323M -3.6x -5.6x
TLSIW Unlock Forecast - 30 Days FREE Trial $40M x -1.9x
TMCI Unlock Forecast - 30 Days FREE Trial $180M -7.5x 2.0x
TNDM Unlock Forecast - 30 Days FREE Trial $1405M -17.1x 10.6x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 2.0x
UFPT Unlock Forecast - 30 Days FREE Trial $1733M 44.7x 4.3x
USAQ Unlock Forecast - 30 Days FREE Trial $3M x x
UTMD Unlock Forecast - 30 Days FREE Trial $177M 15.5x 1.5x
VERO Unlock Forecast - 30 Days FREE Trial $3M 0.0x 1.2x
VYCO Unlock Forecast - 30 Days FREE Trial $6M x x
WST Unlock Forecast - 30 Days FREE Trial $19926M 44.4x 6.5x
XAIR Unlock Forecast - 30 Days FREE Trial $10M -0.3x 0.8x
XTNT Unlock Forecast - 30 Days FREE Trial $87M -478.8x 1.7x

Frequently Asked Questions - TELA Bio, Inc. Stock Forecast

How accurate are TELA Bio, Inc. stock predictions?

Our AI model shows a 24% Spearman correlation coefficient for TELA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence TELA Bio, Inc. stock price forecasts?

Our analysis considers TELA Bio, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is TELA Bio, Inc. a good investment in 2025?

Based on our AI analysis, TELA Bio, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are TELA Bio, Inc. forecasts updated?

TELA Bio, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced TELA Bio, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for TELA Bio, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...